The JRC will organise a high-level conference titled "Integrating genomics into personalised healthcare: a science-for-policy perspective" on the 12th and 13th of February, 2019.
This conference will bring together experts from around the world to discuss the potential of genomics in the prevention, diagnostics, and therapy for cancer and the new opportunities it may bring for citizens and patients in the EU.
The discussions will also highlight challenges to the implementation and uptake of genomics-based screening and diagnosis in health systems and map the appropriate actions.
The focus will be on supporting patient-centric policies, covering important aspects such as quality assurance, ownership and security of the genetic information produced, ethics and the impact of the genomics market on healthcare systems.
The conference will promote cross-disciplinary interactions between specialists in genetics and genomics, health professionals, decision-makers, patient organisations and other relevant stakeholders.
The event supports:
- The implementation of the Communication on enabling the digital transformation of health and care in the Digital Single Market; empowering citizens and building a healthier society
- The Member States' Declaration on joining forces and genomic data to personalise Healthcare.
Conference themes of interest
The conference will be structured into four sessions, reflecting three main themes.
Theme I. Genomics for health: the breast cancer example
What is "genomics"? How does it apply to health? What's in it for me – as a citizen?
Starting from the use of genomics, in the field of breast cancer, the theme will stimulate a broader discussion to illustrate the evolution of genetic testing and gene panels, with a particular focus on:
- How this facilitates bridging the application of whole-genome sequencing into clinical practice.
- How genomics can support better diagnostics, targeted treatments, disease monitoring and clinical follow-up.
Theme II. The public health perspective
What are the opportunities and challenges of implementing genomics approaches in public health? Who are the actors, and what are the actions that are needed for this implementation to succeed?
The theme will foster a debate on public health topics like evidence-generating healthcare, harmonisation, reproducibility, data interoperability, quality and security in the context of genomics.
It will also map out how the process of translating genomic data into the clinical setting could be facilitated, and explain the impact that the genomics market has on healthcare systems.
Theme III. The citizen and patient perspective
How is genomics experienced by people, as patients, consumers, citizens? How will the citizen and the patient be approached and involved? How is the individual's information valued, and who will use and have access to it?
The theme will propose a consideration and reflection on regulatory and ethical challenges with a particular focus on the societal and legal implications for the citizen. It will highlight the importance of literacy, both from citizens, patients and health professionals, and discuss ways to mobilise citizen engagement.
European Commission's Joint Research Centre, Retieseweg 11, 2440 Geel, Belgium
Registration [this event has finished]
The number of participants is restricted to 350.
Tuesday 12 February 2019
08:00 - 09:15 Participants registration and welcome coffee
09:30 - 10:00 Institutional addresses
- Chair: Chairs Vladimír Šucha, Director General, European Commission, Directorate-General Joint Research Centre, Belgium
- Martin Seychell, Deputy Director General, European Commission, Directorate-General for Health and Food Safety, Belgium
- Irene Norstedt, Acting Direcor, European Commission, Directorate-General for Research and Innovation, Belgium
10:00 - 13:15 Session I: Setting the stage - What is "genomics"? How does it apply to health? What's in it for me, as a citizen?
This session will illustrate the evolution of genetic testing and how the application of sequencing technologies led to the discovery of genetic variants and subsequently to the eventual characterisation of disease variants. This ultimately may lead to applications in clinical practice and this session will highlight how genomics can support better diagnostics, targeted treatments, disease monitoring and clinical follow-up.
10:00 - 11:00 Keynote presentations
11:00 - 11:30 Coffee break
11:30 - 13:15 Moderated panel discussion with:
13:15 - 14:45 Lunch break
14:15 - 14:45 Flash talks by young health innovators
14:45 - 18:00 Session II: Genomics - opportunities and challenges - What are the opportunities and challenges of implementing genomics approaches in public health?
This session will discuss concepts such as evidence-generating healthcare, harmonisation, reproducibility, as well as data interoperability, quality and security.
14:45 - 15:45 Keynote presentations
15:45 - 16:15 Break
16:15 - 18:00 Moderated panel discussion with
18:00 End of day 1
18:00 - 19:00 Refreshments
Wednesday 13 February 2019
08:00 - 08:45 Particpants registration
08:45 - 12:00 Session III: The public health perspective - Who are the actors, and what are the actions that are needed for the implementation of genomics in healthcare to succeed?
The session will map how the process of translation of genomics data to the clinical setting could be facilitated, and explain the impact the genomics market has on healthcare systems.
08:45 - 09:45 Keynote presentation
09:45 - 10:15 Coffee break
10:15 - 12:00 Moderated panel discussion with
12:00 - 13:30 Lunch break
13:00 - 13:30 Flash talks: A focus on genomics for rare diseases
13:30 - 16:45 Session IV: The citizen and patient perspective - How is genomics experienced by people, as patients, consumers, citizens? How will the citizen and the patient be approached and involved? How is the individual's information valued, and who will use and have access to it?
This session will discuss regulatory and ethical challenges and considerations, with a particular focus on the societal and legal implications for the citizen. It will highlight the importance of literacy, both from citizens, patients and health professionals, and highlight the ways to mobilise citizen engagement.
13:30 - 14:30 Keynote presentations
14:30 - 15:00 Break
15:00 - 16:45 Moderated panel discussion with
- Jane Kaye, Centre for Law, Health and Emerging Technologies (HeLEX), University of Oxford, United Kingdom
- Bettina Borisch, University of Geneva, Switzerland - Presentation
- Jean-Pierre Hubaux, Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland - Presentation
- Andres Metspalu, University of Tartu, Institute of Genomics, Estonia - Presentation
16:45 - 17:30 Final keynote presentation
17:30 Closing of the conference
If you have further questions, please contact JRCfirstname.lastname@example.org